“Telmisartan Attenuates Experimental Liver Fibrosis Through Suppression Of Hepatic Stellate Cell Activation And Tgf-Β Smad Signaling”. The Review of Diabetic Studies , Dec. 2025, pp. 496-10, https://doi.org/10.70082/y1zx3j95.